AT1 receptor blocker and diuretics in the treatment of arterial hypertension: hemodynamic differences

Delgado, A.; Delgado-Almeida, Antonio; Celis, Susana I.; Delgado-Leon, Carlos L.; Galves, Elymir S.; Rupo, Doriana Di

doi:10.1016/s0895-7061(02)02466-4

Search citation statements

Order By: Relevance

Paper Sections

Select...

P Verdecchia Telmisartan In Cardiac Remodelling1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2005

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…37 Haemodynamic differences between telmisartan and amiloride have also been observed. 38 Both agents reduced SBP and DBP, but telmisartan improved afterload and contractility index, reduced systemic vascular resistance and increased systemic vascular compliance. In contrast, amiloridetreated patients only displayed improvements in contractility index and increased vascular compliance.…”

Section: P Verdecchia Telmisartan In Cardiac Remodellingmentioning

confidence: 94%

Pre-Clinical and Clinical Experience of Telmisartan in Cardiac Remodelling

Verdecchia

2005

J Int Med Res

View full text Add to dashboard Cite

Epidemiological studies have established that left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular and cerebrovascular morbidity and mortality. In turn, hypertension is a well-established risk factor for LVH. Ambulatory blood pressure monitoring has shown that 24-h mean ambulatory blood pressure is a particularly powerful predictor of LVH, being superior to casual clinic blood pressure measurements

show abstract

Section: P Verdecchia Telmisartan In Cardiac Remodellingmentioning

confidence: 94%

Pre-Clinical and Clinical Experience of Telmisartan in Cardiac Remodelling

Verdecchia

2005

J Int Med Res

View full text Add to dashboard Cite

show abstract

AT1 receptor blocker and diuretics in the treatment of arterial hypertension: hemodynamic differences

Cited by 1 publication

References 0 publications

Pre-Clinical and Clinical Experience of Telmisartan in Cardiac Remodelling

Pre-Clinical and Clinical Experience of Telmisartan in Cardiac Remodelling

Contact Info

Product

Resources

About